Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898432-08-000587
Filing Date
2008-06-23
Accepted
2008-06-23 16:38:32
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvfsgxpharm13d.htm SC 13D 108365
  Complete submission text file 0000898432-08-000587.txt   110557
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10505 ROSELLE STREET SAN DIEGO CA 92121 858-558-4850
SGX PHARMACEUTICALS, INC. (Subject) CIK: 0001125603 (see all company filings)

EIN.: 061523147 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-81448 | Film No.: 08912438
SIC: 2834 Pharmaceutical Preparations